Cancer Care Ontario | Cancer Care Ontario

5 Results

Guidelines and Advice

Recommendations for the Treatment of Patients with Clinical Stage III Non-Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance

Status: In-Review
ID: GL END 7-3
Version: 4

Apr 2020

Guidelines and Advice

Status: Current
ID: GL 2-30a
Version: N/A

Mar 2020

Guidelines and Advice

Status: In-Review
ID: 3-22
Version: N/A

Apr 2020

Guidelines and Advice

Status: Current

Apr 2020

Guidelines and Advice

Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Updated

Mar 2025